VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

EHA 2022 | Unmet needs in AL amyloidosis: treatment options for R/R patients

Jahanzaib Khwaja, MD, FRCPath, University College London Hospitals NHS Foundation Trust, London, UK, comments on unmet needs in patients with relapsed/refractory (R/R) AL amyloidosis. Dr Khwaja explains that there are few clinical trials in this setting, and patients have limited treatment options. This interview took place at the European Hematology Association (EHA) Congress 2022 held in Vienna, Austria.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter